Gianfranco Caselli

6PUBLICATIONS
20CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)GlycoconjugatesImage and video codingMolecular medicineCheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 09, 2022
I2-Imidazoline Ligand CR4056 Improves Memory, Increases ApoE Expression and Reduces BBB Leakage in 5xFAD Mice.

Bibiana C Mota, Nathan Ashburner, Laura Abelleira-Hervas

|May 11, 2022
Poly-histidine grafting leading to fishbone-like architectures.

Vincenzo Razzano, Marco Paolino, Annalisa Reale

|Sep 08, 2021
Toxicity and Local Tolerance of COVID- eVax, a Plasmid DNA Vaccine for SARS-CoV-2, Delivered by Electroporation.

Yuval Ramot, Gianfranco Caselli, Luigi Aurisicchio

|Mar 11, 2020
Improved efficacy, tolerance, safety, and abuse liability profile of the combination of CR4056 and morphine over morphine alone in rodent models.

Emanuele Sala, Flora Ferrari, Marco Lanza

|Aug 28, 2019
CR4056, a powerful analgesic imidazoline-2 receptor ligand, inhibits the inflammation-induced PKCε phosphorylation and membrane translocation in sensory neurons.

Vittorio Vellani, Chiara Sabatini, Chiara Milia

|Mar 02, 2018
Pharmacological characterisation of CR6086, a potent prostaglandin E2 receptor 4 antagonist, as a new potential disease-modifying anti-rheumatic drug.

Gianfranco Caselli, Albino Bonazzi, Marco Lanza

Pageof 1

Frequent Collaborators

2 joint publications

Chiara Sabatini

2 joint publications

Chiara Milia

2 joint publications

Marco Lanza

2 joint publications

Lucio Claudio Rovati